Sunday, September 6, 2026
Home Authors Posts by Ogkologos

Ogkologos

4330 POSTS 0 COMMENTS

Strong Independent Association of TILs with OS for Patients with ERBB2-positive...

Ogkologos -
0

Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...

Ogkologos -
0

ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March

Ogkologos -
0

Neoadjuvant Nivolumab Plus Ipilimumab Shows Trend Towards Long-Term Clinical Benefit versus...

Ogkologos -
0

Abnormal Results from Prenatal Blood Test Could Point to Cancer in...

Ogkologos -
0

FDA Approves Acalabrutinib with Bendamustine and Rituximab for Previously Untreated Mantle...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Datopotamab Deruxtecan

Ogkologos -
0

FDA Approves Injectable Nivolumab, an Alternative to IV Infusion

Ogkologos -
0

Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers

Ogkologos -
0

Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended...

Ogkologos -
0
1...505152...433Page 51 of 433

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com